Skip to main content

In Brief This Week: AnaSpec, Biocom Biotech; TriLink BioTechnologies; Transgenomic, iMedicor; Myriad Genetics

NEW YORK (GenomeWeb News) – AnaSpec said this week that Biocom Biotech will serve as non-exclusive distributor of the firm's catalog and custom products throughout South Africa.


TriLink BioTechnologies this week said that it has relaunched its oligonucleotide radiolabeling services, just a few months after it had discontinued the service. The firm said that "strong customer feedback" persuaded the firm to re-start the services.


Transgenomic will work with iMedicor on developing an educational marketing program for Transgenomic's NuroPro diagnostic tests for Alzheimer's and Parkinson's disease. The firms said that the online, alert-based program will target neurologists, gerontologists, and primary care physicians.


Myriad Genetics has launched a hereditary breast and ovarian cancer public awareness campaign in five Midwest states including Illinois, Indiana, Kentucky, Missouri, and Ohio. The campaign is intended to raise the profile of the firm's BRACAnalysis test for detecting the BRCA1 or BRCA2 gene.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.